Nominations of J. Thomas Rosch and William E. Kovacic to be Commissioners..., S. Hrg. 109-318, , November 14, 2005, 109-1 Hearing, *

Nominations of J. Thomas Rosch and William E. Kovacic to be Commissioners..., S. Hrg. 109-318, , November 14, 2005, 109-1 Hearing, * PDF Author: United States. Congress. Senate. Committee on Commerce, Science, and Transportation
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description

Nominations of J. Thomas Rosch and William E. Kovacic to be Commissioners..., S. Hrg. 109-318, , November 14, 2005, 109-1 Hearing, *

Nominations of J. Thomas Rosch and William E. Kovacic to be Commissioners..., S. Hrg. 109-318, , November 14, 2005, 109-1 Hearing, * PDF Author: United States. Congress. Senate. Committee on Commerce, Science, and Transportation
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description


Nominations of J. Thomas Rosch and William E. Kovacic to be Commissioners of the Federal Trade Commission

Nominations of J. Thomas Rosch and William E. Kovacic to be Commissioners of the Federal Trade Commission PDF Author: United States. Congress. Senate. Committee on Commerce, Science, and Transportation
Publisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 32

Get Book Here

Book Description


NOMINATIONS OF J. THOMAS ROSCH AND WILLIAM... HEARING... S. HRG. 109-318... COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION, U.S. SENATE.

NOMINATIONS OF J. THOMAS ROSCH AND WILLIAM... HEARING... S. HRG. 109-318... COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION, U.S. SENATE. PDF Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description


CIS Annual

CIS Annual PDF Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 672

Get Book Here

Book Description


Nominations of Deborah Taylor Tate and Michael J. Copps to be Commissioners of The Federal Communications Commission, S. Hrg. 109-319, December 13, 2005, 109-1 Hearing, *

Nominations of Deborah Taylor Tate and Michael J. Copps to be Commissioners of The Federal Communications Commission, S. Hrg. 109-319, December 13, 2005, 109-1 Hearing, * PDF Author: United States. Congress. Senate. Committee on Commerce, Science, and Transportation
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description


Pharmaceutical R&D

Pharmaceutical R&D PDF Author:
Publisher: DIANE Publishing
ISBN: 9780788104688
Category : Drugs
Languages : en
Pages : 380

Get Book Here

Book Description
Analyzes the costs, risks, and economic rewards of pharmaceutical R&D and the impact of public policy on both costs and returns. Examines the rapid increase in pharmaceutical R&D that began in the 1980s in the light of trends in science, technology, drug discovery, and health insurance coverage; Government regulation; product liability; market competition; Federal tax policy; and Federal support of prescription drug research. 12 appendices, including a glossary of terms.

Generic drug entry prior to patent expiration an FTC study

Generic drug entry prior to patent expiration an FTC study PDF Author:
Publisher: DIANE Publishing
ISBN: 1428951938
Category :
Languages : en
Pages : 129

Get Book Here

Book Description


Research and Development in the Pharmaceutical Industry (A CBO Study)

Research and Development in the Pharmaceutical Industry (A CBO Study) PDF Author: Congressional Budget Office
Publisher: Lulu.com
ISBN: 1304121445
Category : Science
Languages : en
Pages : 65

Get Book Here

Book Description
Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...

Budget Options

Budget Options PDF Author: United States. Congressional Budget Office
Publisher:
ISBN:
Category : Budget
Languages : en
Pages : 240

Get Book Here

Book Description